New York's Chelsea Gallery District becomes the launch pad for a dystopian spectacle masquerading as a campaign rollout.

“Project 29” marks, in XVALA's view, the true launch of Trump's third-term campaign. Edwards, by contrast, relishes the ...

Rational AG Annual stock financials by MarketWatch. View the latest 1RAA financial statements, income statements and financial ratios. Skip to main content Main Menu Latest News Watchlist ...

The CEO of a small cap biotech has been sanctioned by the British Columbia Securities Commission (BCSC) for failing to file insider trading reports on time.

And general manager Eric DeCosta insists that's not by accident, revealing in a recent interview that he believes the "only rational approach" to the NFL draft is to accumulate as many picks as ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

The company and other insurers have faced backlash from patients who say they were denied necessary care and providers say ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Rational Dynamic Brands Fund earns a Below Average Process Pillar rating. The process is strengthened by the firm's retention rate of the firm's portfolio managers, which is 89% over the available ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.

Ph.D., MBA, Chief Executive Officer, Vir Biotechnology. "We successfully dosed the first patient in our ECLIPSE Phase 3 registrational program for hepatitis delta, a devastating disease with no ...